Ontology highlight
ABSTRACT: Background
Treatments for cancer cachexia, defined as involuntary weight and muscle mass loss leading to significant functional impairment, remain unavailable partly due to insufficient improvement of clinically meaningful outcomes in current trials. By reflecting downstream effects of cellular function, metabolomics may identify mechanisms contributing to poor functional performance. Previous metabolomic studies in cancer cachexia have identified alterations in amino acid metabolism with weight loss or low muscularity; none have examined perturbations with poor physical function. We hypothesized that distinct metabolic signals in plasma and muscle are associated with weight loss, low muscle mass, and impaired function in cancer cachexia.Methods
We enrolled patients plannin
SUBMITTER: Anderson LJ
PROVIDER: S-EPMC12813416 | biostudies-literature | 2026 Feb
REPOSITORIES: biostudies-literature